0.1(top 100%)
impact factor
196(top 50%)
papers
223(top 50%)
citations
6(top 50%)
h-index
0.2(top 100%)
extended IF
200
all documents
236
doc citations
11(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1The Fractal-like Complexity of Heart Rate Variability beyond Neurotransmitters and Autonomic Receptors: Signaling Intrinsic to Sinoatrial Node Pacemaker CellsCardiovascular Pharmacology: Open Access201326
2CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy via PGC-1α ActivationCardiovascular Pharmacology: Open Access201824
3Cardio-Ankle Vascular Index (CAVI) and its Potential Clinical Implications for Cardiovascular DiseaseCardiovascular Pharmacology: Open Access201310
4AMP-Activated Protein Kinase Signalling in Cancer and Cardiac HypertrophyCardiovascular Pharmacology: Open Access20159
5Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel TargetCardiovascular Pharmacology: Open Access20177
6Sodium Glucose Transporter 2 (SGLT2) Inhibition does not Protect the Myocardium from Acute Ischemic Reperfusion Injury but Modulates Post- Ischemic Mitochondrial FunctionCardiovascular Pharmacology: Open Access20177
7A Study of the Effect of Isoproterenol on Red Blood Cell Concentrations of Adenine Nucleotides in a Freely Moving Rat Model In Vivo*Cardiovascular Pharmacology: Open Access20136
8A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1Cardiovascular Pharmacology: Open Access20156
9Switching of Ticagrelor to Clopidogrel at 3 Months in Patients Treated for Acute Care Syndrome; Single Centre ExperienceCardiovascular Pharmacology: Open Access20166
10Resolution of Left Ventricular Thrombus after Dabigatran Therapy in Two Patients with Old Anteroseptal Myocardial InfarctionCardiovascular Pharmacology: Open Access20156
11The Probability of Inconstancy in Assessment of Cardiac Function Post- Myocardial Infarction in MiceCardiovascular Pharmacology: Open Access20166
12ATP Metabolism as Biomarker Target for Cardiovascular ProtectionCardiovascular Pharmacology: Open Access20136
13Acenocoumarol in Thromoembolic DisordersCardiovascular Pharmacology: Open Access20155
14Measuring Platelet Reactivity after Clopidogrel-Has it Reached the End of the Road?Cardiovascular Pharmacology: Open Access20134
15Drugs for the Prevention and Treatment of Cardiac Allograft VasculopathyCardiovascular Pharmacology: Open Access20144
16Current and Potential Antiarrhythmic Drugs Targeting Voltage-Gated Cardiac Ion ChannelsCardiovascular Pharmacology: Open Access20154
17Impact of the New P2Y12 Receptor Inhibitors on Mortality in STElevation Myocardial Infarction Patients with Cardiogenic Shock and / or After Cardiopulmonary Resuscitation Undergoing Percutaneous Coronary InterventionCardiovascular Pharmacology: Open Access20164
18Effects of JNJ-54452840, an Anti-β1 Receptor Antibody Cyclopeptide in Heart Failure Patients: A Randomized, Double-blind, Parallel-group, Phase-2 Pilot StudyCardiovascular Pharmacology: Open Access20164
19Re-evaluation of Bleeding Events in the Japanese PRASFIT-Elective and PRASFIT-ACS Clinical Trials using the Bleeding Academic Research Consortium CriteriaCardiovascular Pharmacology: Open Access20153
20Recombinant Human Elastase Treatment of Cephalic VeinsCardiovascular Pharmacology: Open Access20163
21From Arctic to Antarctic: Is There any Remaining Role for Platelet Function Testing to Tailor Therapy after Coronary Stent Implantation?Cardiovascular Pharmacology: Open Access20163
22Supraphysiological Testosterone Levels Shorten the QT Interval but do Not Alter Total Anatomic Myocardial Infarct Size in Rabbits with Acute Myocardial InfarctionCardiovascular Pharmacology: Open Access20143
23Pharmacological Inhibition of Phosholipase A2: Results from Phase 3 Clinical Trials with Darapladib and Varespladib in Patients with Cardiovascular DiseaseCardiovascular Pharmacology: Open Access20153
24Effect of Vildagliptin, Compared to Sitagliptin, on the Onset of Hyperglycemia-Induced Metabolic Memory in Human Umbilical Vein Endothelial CellsCardiovascular Pharmacology: Open Access20173
25Mechanism of Gender-Related Differences in Vascular FunctionCardiovascular Pharmacology: Open Access20183
26Exploring Future Cardiovascular Medicine: Heart Precursors Directed From Human Embryonic Stem Cells For Myocardium RegenerationCardiovascular Pharmacology: Open Access20133
27Reviving Cell-Based Regenerative Medicine for Heart Reconstitution with Efficiency in Deriving Cardiac Elements from Pluripotent Human Embryonic Stem CellsCardiovascular Pharmacology: Open Access20133
28Preventing Recurrences: Classic and Modern Antiarrhythmic Drugs in Atrial FibrillationCardiovascular Pharmacology: Open Access20142
29Relation of Cholesterol Level to Dietary Fat Intake in Patients of Ischemic Heart DiseaseCardiovascular Pharmacology: Open Access20152
30Trials Evaluating Ticagrelor in Cardiovascular Disease: Will It Reign Supreme in the Anti-Platelet World?Cardiovascular Pharmacology: Open Access20172
31Down Syndrome with Unbalanced Complete Atrioventricular Septal Defect and Truncus ArteriosusCardiovascular Pharmacology: Open Access20172
32Anti-Thrombotic Drug ProblemsCardiovascular Pharmacology: Open Access20182
33Transhepatic Approach for Device Closure of Secundum Atrial Septal Defect in Patient with Interrupted Inferior Vena CavaCardiovascular Pharmacology: Open Access20142
34Acute Myocardial Injury: A Perspective on Lethal Reperfusion InjuryCardiovascular Pharmacology: Open Access20172
35Potential of Monocyte Count for the Assessment of Cardiovascular DiseaseCardiovascular Pharmacology: Open Access20172
36MicroRNA Therapeutics for Cardiac DiseaseCardiovascular Pharmacology: Open Access20132
37Role of Bone Morphogenetic Protein Type II Receptor Signaling in Pulmonary Arterial HypertensionCardiovascular Pharmacology: Open Access20132
38Coenzyme Q10 for Cardiovascular PreventionCardiovascular Pharmacology: Open Access20142
39Application of Intima Media Thickness Measurement and Omics in Intrauterine Growth Restriction DiseaseCardiovascular Pharmacology: Open Access20142
40Dexmedetomidine: The Anesthetic as an AntiarrythmicCardiovascular Pharmacology: Open Access20152
41Endothelial Dysfunction Induced by Chronic Psychological Stress: A Risk Factor for AtherosclerosisCardiovascular Pharmacology: Open Access20152
42Apocynin Exerts Dose-Dependent Cardioprotective Effects by Attenuating Reactive Oxygen Species in Ischemia/ReperfusionCardiovascular Pharmacology: Open Access20162
43Cardio-Oncology: A Tale of Two DiseasesCardiovascular Pharmacology: Open Access20172
44Hypertrophic and Inflammatory Markers in Isoproterenol-Induced CardiacHypertrophy and its Pharmacological CorrectionCardiovascular Pharmacology: Open Access20172
45Complementary Effect of Exercise in Cardiovascular MedicineCardiovascular Pharmacology: Open Access20131
46Stress as a Risk Factor for Cardiovascular EventsCardiovascular Pharmacology: Open Access20151
47Clinical Care for the Patient with Heart Failure: A Nursing Care PerspectiveCardiovascular Pharmacology: Open Access20151
48Pharmacotherapy in the Cardiac Catheterization LaboratoryCardiovascular Pharmacology: Open Access20151
49Early Subclinical Biomarkers in Onco-Cardiology to Prevent Cardiac DeathCardiovascular Pharmacology: Open Access20151
50Molecular Basis for Mercury-Induced Alteration in Endothelial Function: NO and its ModulatorsCardiovascular Pharmacology: Open Access20151